Stay updated on Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Sign up to get notified when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.

Latest updates to the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 on the page, indicating a site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedFooter revision indicator updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedNo significant changes detected between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI updates include a new 'Show glossary' option and updated footer metadata (Last Update Submitted that Met QC Criteria) plus a new Revision: v3.4.0. Minor capitalization changes (No FEAR Act data) accompany these updates.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study's Locations section was updated with removals of several locations (e.g., California, Texas, Minsk Oblast, Bács-Kiskun county, MI, RM, Leningradskaya Oblast, Republic Bashkortost, Ryshkovskiy Village Council, Stavropol Kray, Volgograd Oblast) and additions of new locations across multiple regions (including Minsk Oblast and other areas).SummaryDifference0.9%

Stay in the know with updates to Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.